Cargando…
New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy
Over the last 20 years, granulocyte colony-stimulating factors (G-CSFs) have become the major therapeutic option for the treatment of patients with neutropenia. Most of the current G-CSFs require daily injections, which are inconvenient and expensive for patients. Increased understanding of G-CSFs’...
Autores principales: | Theyab, Abdulrahman, Alsharif, Khalaf F., Alzahrani, Khalid J., Oyouni, Atif Abdulwahab A., Hawsawi, Yousef MohammedRabaa, Algahtani, Mohammad, Alghamdi, Saad, Alshammary, Amal F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850083/ https://www.ncbi.nlm.nih.gov/pubmed/36686781 http://dx.doi.org/10.3389/fonc.2022.1026377 |
Ejemplares similares
-
Prostate cancer and therapeutic challenges
por: Hawsawi, Yousef MohammedRabaa, et al.
Publicado: (2020) -
Association of SNPs within TMPRSS6 and BMP2 genes with iron deficiency status in Saudi Arabia
por: Al-Amer, Osama M., et al.
Publicado: (2021) -
BARD1 mystery: tumor suppressors are cancer susceptibility genes
por: Hawsawi, Yousef M., et al.
Publicado: (2022) -
Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy
por: Al-Numair, Nouf S., et al.
Publicado: (2022) -
Correction: Camels’ biological fluids contained nanobodies: promising avenue in cancer therapy
por: Al‑Numair, Nouf S., et al.
Publicado: (2023)